Tranilast : A Pharmaceutical Candidate for Reduction of Adhesions Using a Novel ApproachPETRILLI, Janel; WADSWORTH, Scott; COOPER, Kevin et al.Seminars in reproductive medicine. 2008, Vol 26, Num 4, pp 341-348, 8 p.Article

Osteogenic Activity of Locally Applied Small Molecule Drugs in a Rat Femur Defect ModelCOTTRELL, Jessica A; VALES, Francis M; SCHACHTER, Deborah et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 597641.1-597641.11, 2Article

Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast CancerRHODES, Lyndsay V; SHORT, Sarah P; FONSECA, Juan P et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 2, pp 603-613, issn 0008-5472, 11 p.Article

Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinaseBRATTON, Melyssa R; FRIGO, Daniel E; VIGH-CONRAD, Katinka A et al.Carcinogenesis (New York. Print). 2009, Vol 30, Num 1, pp 106-113, issn 0143-3334, 8 p.Article

Drugs Designed To Inhibit Human p38 Mitogen-Activated Protein Kinase Activation Treat Toxoplasma gondii and Encephalitozoon cuniculi InfectionSHUANG WEI; DANIEL, Benjamin J; BRUMLIK, Michael J et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 12, pp 4324-4328, issn 0066-4804, 5 p.Article

Inhibitors of unactivated p38 MAP kinaseBULLINGTON, James; ARGENTIERI, Dennis; LEUNG, Wai-Ping et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 23, pp 6102-6106, issn 0960-894X, 5 p.Article

HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation. CommentaryMUTHUMANI, Karuppiah; CHOO, Andrew Y; PERFETTINI, Jean-Luc et al.Blood. 2005, Vol 106, Num 6, pp 1899-1900, issn 0006-4971, 12 p.Article